HILDEN, Germany & ANN ARBOR, Mich.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company ...
SEOUL, South Korea, April 9, 2025 /CNW/ -- Seegene Inc., a global leader in molecular diagnostics (MDx), is advancing its vision for innovation in laboratory automation with the development of CURECA™ ...
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to ...
Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testing Introduction of CURECA™, the first fully unattended PCR automation system, ...
Automated quality control has moved to the center of biopharmaceutical manufacturing strategy, and the clearest evidence is the displacement of weeks-long culture-based tests by rapid polymerase chain ...
Leading PCR and qPCR technology now available for high-throughput applications: With the Biometra TRobot II and qTOWER³ auto, Analytik Jena presents two new thermal cyclers for fully automated PCR and ...
Find out how to make the right decisions for your lab. PCR is a cornerstone technology for genetic research and many molecular diagnostic-based tests. As projects become larger and more clinics adopt ...
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to ...